Molly Maloy

5.2k total citations
111 papers, 1.6k citations indexed

About

Molly Maloy is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Molly Maloy has authored 111 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 40 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Molly Maloy's work include Hematopoietic Stem Cell Transplantation (58 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (21 papers). Molly Maloy is often cited by papers focused on Hematopoietic Stem Cell Transplantation (58 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (21 papers). Molly Maloy collaborates with scholars based in United States, Spain and Italy. Molly Maloy's co-authors include Miguel‐Angel Perales, Sergio Giralt, Ann A. Jakubowski, Sean M. Devlin, Esperanza B. Papadopoulos, Craig S. Sauter, Parastoo B. Dahi, Michael Scordo, Juliet N. Barker and Hugo Castro‐Malaspina and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Molly Maloy

104 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Molly Maloy United States	22	834	635	304	236	226	111	1.6k
Parastoo B. Dahi United States	18	930 1.1×	494 0.8×	249 0.8×	229 1.0×	304 1.3×	111	1.7k
Mike Potter United Kingdom	24	409 0.5×	823 1.3×	510 1.7×	370 1.6×	186 0.8×	63	1.7k
Gunjan L. Shah United States	24	1.1k 1.3×	489 0.8×	215 0.7×	261 1.1×	301 1.3×	188	1.9k
Francesc Fernández‐Avilés Spain	24	532 0.6×	1.2k 1.8×	337 1.1×	440 1.9×	139 0.6×	89	1.8k
Richard Champlin United States	15	325 0.4×	870 1.4×	299 1.0×	351 1.5×	259 1.1×	32	1.5k
Jeffery J. Auletta United States	22	369 0.4×	478 0.8×	229 0.8×	354 1.5×	263 1.2×	115	1.5k
M Kalaycio United States	24	626 0.8×	980 1.5×	224 0.7×	276 1.2×	146 0.6×	76	1.8k
Yukiko Kishi Japan	22	456 0.5×	531 0.8×	280 0.9×	210 0.9×	176 0.8×	61	1.2k
Stefania Varotto Italy	23	382 0.5×	525 0.8×	134 0.4×	176 0.7×	93 0.4×	42	1.2k
Donna Salzman United States	18	368 0.4×	358 0.6×	372 1.2×	114 0.5×	302 1.3×	57	1.2k

Countries citing papers authored by Molly Maloy

Since Specialization

Citations

This map shows the geographic impact of Molly Maloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Maloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Maloy more than expected).

Fields of papers citing papers by Molly Maloy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Maloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Maloy. The network helps show where Molly Maloy may publish in the future.

Co-authorship network of co-authors of Molly Maloy

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Maloy. A scholar is included among the top collaborators of Molly Maloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Maloy. Molly Maloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Melica, Giovanna, Kenneth Seier, Florent Malard, et al.. (2024). Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation. Bone Marrow Transplantation. 59(5). 625–629.

Ploeg, Kattria van der, Rosa Sottile, Brian C. Shaffer, et al.. (2023). Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. Blood Advances. 7(19). 5784–5798. 5 indexed citations

Sánchez‐Escamilla, Miriam, Jessica Flynn, Sean M. Devlin, et al.. (2023). EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 58(5). 498–505. 14 indexed citations

Brown, Samantha, Stephanie Lobaugh, Sean M. Devlin, et al.. (2023). Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review. Journal of the Advanced Practitioner in Oncology. 14(2). 127–137. 1 indexed citations

Lin, Andrew, Samantha Brown, Molly Maloy, et al.. (2022). Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 63(7). 1686–1693. 2 indexed citations

Lavery, Jessica A., Molly Maloy, Fernanda Polubriaginof, et al.. (2022). Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study. Cancer Epidemiology Biomarkers & Prevention. 31(5). 1036–1042. 2 indexed citations

Lee, Jeong‐Ok, Jessica Flynn, Molly Maloy, et al.. (2022). CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis. Bone Marrow Transplantation. 57(7). 1101–1107. 4 indexed citations

Lahoud, Oscar, Sean M. Devlin, Molly Maloy, et al.. (2021). Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation. Blood Advances. 5(14). 2879–2889. 18 indexed citations

Jee, Justin, Michael B. Foote, Melissa Lumish, et al.. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology. 38(30). 3538–3546. 173 indexed citations

10.

Gutgarts, Victoria, Tania Jain, Junting Zheng, et al.. (2020). Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery. Biology of Blood and Marrow Transplantation. 26(6). 1071–1076. 66 indexed citations

11.

Gutgarts, Victoria, Insara Jaffer Sathick, Junting Zheng, et al.. (2020). Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 26(4). 758–763. 11 indexed citations

12.

Lin, Andrew, Molly Maloy, Yiqi Su, et al.. (2019). Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience. Transplant Infectious Disease. 21(6). e13187–e13187. 65 indexed citations

13.

Lin, Richard J., Koshy Alexander, Abigail Cohen, et al.. (2019). Characteristics of Peri-Transplant Palliative Supportive Care Consultation Among Older Allogeneic Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 25(3). S134–S134.

14.

Scordo, Michael, Valkal Bhatt, Patrick Hilden, et al.. (2019). Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1526–1535. 17 indexed citations

15.

Lin, Richard J., Sean M. Devlin, Armin Shahrokni, et al.. (2019). Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplantation. 55(1). 157–164. 32 indexed citations

16.

Rondon-Clavo, Carlos, Michael Scordo, Patrick Hilden, et al.. (2018). Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(12). 2517–2522. 14 indexed citations

17.

Barba, Pere, Rodrigo Martino, Qin Zhou, et al.. (2018). CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 24(5). 964–972. 16 indexed citations

18.

Huang, Yao-Ting, Seong-Jin Kim, Yeon Joo Lee, et al.. (2017). Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell–Depleted, CD34+ Selected Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(10). 1759–1766. 31 indexed citations

19.

Huang, Yao-Ting, Dionysios Neofytos, Julia Foldi, et al.. (2016). Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(8). 1480–1486. 28 indexed citations

20.

Seo, Susan K., Kun Xiao, Yao-Ting Huang, et al.. (2014). Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study. Journal of Infection. 69(4). 341–351. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact